Takeda Pharmaceutical stock pre-market at EUR 16.55: unchanged
Published on 10/09/2026 at 08:21 | Editorial responsibility: Rafael MĂĽller, Editor-in-Chief AD HOC NEWSKey points in brief
- Takeda Pharmaceutical stock was unchanged at EUR 16.55 pre-market.
- Lang & Schwarz quoted a EUR 16.00 bid and EUR 17.10 ask.
- ESMO 2026 oncology presentations are scheduled for October 23-27, 2026.
Takeda Pharmaceutical stock was unchanged at EUR 16.55 in pre-market trading at Lang & Schwarz at 8:19 a.m. CEST on October 9, 2026, versus the prior close of EUR 16.55 on October 8, 2026. The bid was EUR 16.00 and the ask was EUR 17.10.
Pre-market trading
The quoted price was unchanged against the prior close at Lang & Schwarz. The further course from the Xetra open at 9:00 a.m. CET/CEST is shown by the continuously updated real-time quote of Takeda Pharmaceutical stock.
What matters today
Takeda’s next scheduled oncology data event is the European Society for Medical Oncology Congress in Madrid from October 23 through October 27, 2026, with a late-breaking presentation scheduled for October 23 at 1:30 p.m. CEST, according to Business Wire. Lang & Schwarz’s 52-week high is EUR 19.10, which is 15.41 percent above the pre-market price. Takeda’s P/E ratio was 52.04 as of October 8, 2026.
Market context: Market report S&P 500.
